Indication

Myotonia

1 clinical trial

1 product

1 drug

Clinical trial

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1

Status: Not yet recruiting, Estimated PCD: 2026-10-01

Product

Drug